Hall v. Abbott Laboratories
Case Number:
1:22-cv-00071
Court:
Nature of Suit:
365 Personal Inj. Prod. Liability
Judge:
Honorable Rebecca R. Pallmeyer
Firms
- Babin Law
- Thornton Law Firm PC
- Colson Hicks
- Cates Law
- Simmons Hanly
- Hastings Law Firm PC
- Eckert Seamans
- Steptoe LLP
- Frost Law Firm PC
- Michael Best & Friedrich LLP
- Peiffer Wolf
- Covington & Burling
- Greenberg Traurig
- Parker Waichman
- Ratzan Weissman
- Gallagher Law Firm PLC
- Knapp & Roberts
- Goss Law Firm PC
- Levin Papantonio
- CohenMalad
- Calwell Luce
- Frazer PLC
- Johnson Kraeuter
- Goodwin & Goodwin LLP
- Waters Kraus
- Goldenberg Lauricella
- Welsh & Recker
- Motley Rice
- Babbitt & Johnson
- Nachawati Law
- Akerman LLP
- Wilson Turner Kosmo
- Locks Law Firm
- Martin & Jones PLLC
- Winston & Strawn
- Allen & Nolte
- Wagstaff Law Firm
- Nace Law Group
- Tinsman & Sciano
- Watts Law Firm
- Arnold & Itkin
- Fulmer Sill
- Herzfeld Suetholz
- Plymale Law Firm
- Swanson Martin
- Napleton & Partners
- Irpino Avin
- Kirkland & Ellis
- Miller Weisbrod
- Blankenship Law Firm
- Harris Lowry
- Freese & Goss
- Morgan & Morgan
- Romanucci & Blandin
- Morris Bart
- Childers Schlueter
- Gorayeb & Associates
- Dilley Law Firm
- DiCello Levitt
- Napoli Shkolnik
- Singleton Schreiber
- Bennerotte & Associates
- Ferrer Poirot
- Lieff Cabraser
- Keller Postman
- Bowersox Law Firm
- Dugan Law Firm
- Brinker & Doyen
- Ben Martin Law
- Thornton Law Firm LLP
- Aylstock Witkin
- Wagstaff & Cartmell
- Robinson Calcagnie
- Anapol Weiss
- DV Injury Law
- Jason J. Joy & Associates
- Levin Rojas
- CR Legal Team
- Chaffin Luhana LLP
- Jones Day
- Simon Greenstone
- Beasley Allen
- Cohen Milstein
- Schlichter Bogard
- Berger Montague
- Johnson & Bell
- Oliver Bell Group
- Johnson Becker
- Grant & Eisenhofer
- Wallace Miller
Companies
- Children's National Hospital
- Einstein Healthcare Network
- Mead Johnson Nutrition Co.
- Abbott Laboratories
- Thomas Jefferson University Hospitals Inc.
Sectors & Industries:
-
July 28, 2025
2nd Abbott Baby Formula Bellwether Falls Before Trial
An Illinois federal judge handed Abbott Laboratories summary judgment on Monday in the second bellwether that had been set for trial in multidistrict litigation over allegations its cow's milk-based formula can cause severe gastrointestinal illness in premature babies, while saying she will leave the door open to revive and later try the case.
-
January 01, 2025
Trials To Watch In 2025
The coming year will bring the first bellwether trials in the closely watched federal baby formula mass litigation, the first courtroom battle over a COVID-19 vaccine patent and six major retailers' case against Visa and Mastercard over card swipe fees.
-
December 12, 2024
JPML Won't Send Infant Formula Suit Back To State Court
The Judicial Panel on Multidistrict Litigation has declined to remand a suit to California state court in an MDL over allegations that the Similac and Enfamil formulas for preterm babies have a higher propensity to cause necrotizing enterocolitis, rejecting the argument by plaintiffs that jurisdiction is lacking.
-
July 31, 2024
5 Trials To Watch In The 2nd Half Of 2024
Upcoming high-profile trials over star lawyer Tom Girardi's alleged fraud, Hunter Biden's taxes and Washington state's "patent troll" law are among the cases to watch in the latter half of the year.
-
March 06, 2024
Judge May Sit In On Depos In Abbott Formula MDL
An Illinois federal judge overseeing multidistrict litigation in which Abbott Laboratories' Similac infant formula is alleged to have caused a deadly illness in premature babies said Wednesday she would hold off on appointing a special master following claims of improper deposition conduct, offering to tune in to depositions to help move things along.
-
June 23, 2022
'Absurd' Loophole Keeping Abbott Formula Suits Federal Fails
An Illinois federal judge overseeing multidistrict litigation alleging Abbott Laboratories' Similac infant formula caused a deadly illness in premature babies on Wednesday remanded four of the cases to state court, finding that allowing the medical company to use the "snap removal" loophole would "produce absurd results."